MMS Holdings

MMS Partners With I-ACT To Advance Children’s Clinical Trials

CANTON - MMS Holdings, a data-focused contract research organization – announced its partnership with the Institute for Advanced Clinical Trials to accelerate the development of life-saving therapeutics, including vaccines, medicines, and medical devices for children. MMS is a sponsor of I-ACT’s Spin Challenge, a creative way to raise funds to advance and accelerate children’s clinical

By |2023-02-27T13:20:31-05:00February 25th, 2023|New Products, New Products / Contracts|

MMS Holdings Names Two Executive Vice Presidents

CANTON – Life Sciences company MMS Holdings Inc. has appointed Kelly J. Hill to Executive Vice President of Global Business Operations and Strategy and Michelle Gayari to Executive Vice President of Global Operational Excellence and Innovation. Hill and Gayari are long-time members of the executive leadership team at MMS, which has remained unchanged for the

By |2021-07-25T13:23:10-04:00July 25th, 2021|Life Sciences, Life Sciences/Biotech|

MMS Holdings Selected To Support COVID-19 Data Alliance Initiative

CANTON - Health Data Research UK has selected Canton-based MMS Holdings – a data-focused clinical research organization – to support the International COVID-19 Data Alliance initiative, providing data engineering services to support a globally coordinated, health data-led research response to tackle the COVID-19 pandemic. MMS was selected from a pool of some of the world’s

By |2021-07-20T12:23:38-04:00July 17th, 2021|Coronavirus, Life Sciences, Life Sciences/Biotech, Science|